• Home
  • NEW DAY MEDICINE
  • 10 (84) 2025
  • 7 -10 (84) 2025 - Yuldosheva D.Kh., Akhmedov Sh.J. - MODERN VIEWS OF THE DEVELOPMENT OF OSTEOPOROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (LITERATURE REVIEW AND OWN DATA)

7 -10 (84) 2025 - Yuldosheva D.Kh., Akhmedov Sh.J. - MODERN VIEWS OF THE DEVELOPMENT OF OSTEOPOROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (LITERATURE REVIEW AND OWN DATA)

MODERN VIEWS OF THE DEVELOPMENT OF OSTEOPOROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (LITERATURE REVIEW AND OWN DATA)

Yuldosheva D.Kh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Akhmedov Sh.J. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This article presents information based on a literature review on the risk factors for osteoporosis in nonalcoholic fatty liver disease, which is the most common digestive system disease and causes disability in the population. It also highlights the importance of molecular and genetic mechanisms for the development of osteoporosis in nonalcoholic fatty liver disease.

Keywords: Nonalcoholic fatty liver disease, osteoporosis, hyperlipidemia, steatosis, vitamin D.

First page

46

Last page

49

For citation:Yuldosheva D.Kh., Akhmedov Sh.J. - MODERN VIEWS OF THE DEVELOPMENT OF OSTEOPOROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (LITERATURE REVIEW AND OWN DATA)//New Day in Medicine 10(84)2025 46-49 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

  1. Cao L, An Y, Liu H, Jiang J, Liu W, Zhou Y, Shi M, Dai W, Lu Y, Zhao Y, Lu Y, Chen L, Xia Y. Global epidemiology of type 2 diabetes mellitus in patients with NAFLD or MAFLD: a systematic review and meta-analysis. // BMC Med. 2024 Mar 6; 22(1):101. doi: 10.1186/s12916-024-03315-0. PMID: 38448943
  2. Cui A, Xiao., Fan Z, Lei J, Han S, Zhang D, Wei S, Wang., Zhuang Y. Causal association of NAFLD with osteoporosis, fracture and falls risk: a bidirectional Mendelian randomization study. Anterior Endocrinol (Lausanne). 2023 Aug 9;14:1215790. DOI: 10.3389/fendo.2023.1215790. Collection 2023.PMID: 37621646
  3. Hansen SG, Wernberg KW, Grønkjær LL, Jacobsen BG, Caterino TD, Krag A, Juhl KB, Lauridsen MM, Shanbhog VV. Are nonalcoholic fatty liver disease and bone mineral density associated? - A cross-sectional study using liver biopsy and dual-energy X-ray absorptiometry. JBMR Plus. 2023 Jan 11; 7(3):e10714. DOI: 10.1002/jbm4.10714. Collection 2023 Mar.PMID: 36936359
  4. Hassan AM, Haridi MA, Shoair MZ, Abdel-Aziz TM, Kura MK, Kenawy EM, Mansour TM, Salaheldin Elsayed S, Ali WE, Abdelmeguid MM, Abdel-Gawad M. Non-alcoholic fatty liver disease is associated with decreased bone mineral density in Upper Egyptian patients. Sci Rep. 2023 Mar 16; 13(1):4353. DOI: 10.1038/s41598-023-31256-w.PMID: 36928441
  5. Pan B, Cai J, Zhao, Liu J, Fu S, Jing G, Niu Q, Li Q. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Osteoporos Int. 2022 Nov; 33(11):2275–2286. DOI: 10.1007/s00198-022-06459-y. Epub 2022 Jun 28. PMID: 35764892 Review.
  6. Roderburg K, Krieg S, Krieg A, Demir M, Ludde T, Kostev K, Liesen SH Eur J Non-alcoholic fatty liver disease (NAFLD) is associated with increased incidence of chronic kidney disease (CKD). Med Res. 2023 Apr 17;28(1):153. doi: 10.1186/s40001-023-01114-6. PMID: 37062837
  7. Roderburg K, Losen S, Kostev K, Demir M, Jordens MS, Ludde T. Non-alcoholic fatty liver disease is associated with a higher incidence of celiac disease. Eur J Gastroenterol Hepatol. 2022 Mar 01;34(3):328-331. doi: 10.1097/MEG.00000000000002234. PMID: 34138765
  8. Vachliotis ID, Anastasilakis AD, Goulas A, Goulis DG, Polizos SA. Non-alcoholic fatty liver disease and osteoporosis: potential link to treatment implications. Diabetes Obesity Metab. 2022 Sep; 24(9):1702–1720.
  9. Xamrayev А.А., Yuldosheva D.X., Zokirov V.Z., Muxammedova Z.R. Clinical-laboratory markers of progression of non-alcoholic fatty liver disease // American Journal of Medicine and Medical Sciences. – USA, 2021;11(5):419-425.
  10. Xamrayev А.А., Yuldosheva D.X., Шамсиева Т.Т., Хайдаров Д.Б. Diagnostic significance of molecular-genetic markers in the development of non-alcoholic fatty liver disease // Тиббиётда янги кун журнали. – Тошкент, 2022;9(47):374-381.
  11. Yuldasheva D.H. Shadjanova N.S., Oltiboyev R.O. Non-alcoholic fatty liver disease and modern medicine // Academicia an international multidisciplinary research journal 2020 Nov;10(11):1931-1937.
  12. Yuldasheva D.H., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver disease: Modern view of the problem // A Multidisciplinary Peer Reviewed Journal.Vol.6. Issue 12. Dec.2020. – P. 286 – 292.
  13. Yuldosheva D.X. Diagnostic significance of laboratory markers, inflammatory and anti – inflammatory cytokines in the development of non-alcoholic fatty liver disease steatosis and steatohepatitis // British Medical Journal, 2022;3:26-35.
  14. Yuldosheva D.X. Prevalence of non- alcoholic fatty liver disease, clinical and laboratory markers // Eurasian journal of medical and natural sciences. Tashkent. 2022; 94-100 pp.
  15. Yuldosheva D.X. Reletionship to the refluxate type of the effectiveness of treatment degree of gastroesophageal reflux disease // European Journal of Research. Austria, Vienna. 2019;2:110-114.
  16. Yuldosheva D.X., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver: modern view of the problem // Multidisciplinary Peer reviewed journal. India. 2020;6(12):286-292.
  17. Zhai T, Chen Q, Xu J, Jia S, Xia. Prevalence and trends of low bone density, osteopenia, and osteoporosis in US adults with nonalcoholic fatty liver disease, 2005–2014. Anterior Endocrinol (Lausanne). 2022 Jan 19;12:825448. DOI: 10.3389/fendo.2021.825448. eCollection 2021. PMID: 35126317
  18. Zhang G, Zhao Y, Wang S, Gong Q, Li HJ. Association between non-alcoholic fatty liver disease and bone mineral density in elderly Chinese. Orthop Surg Res. 2023 Sep 13; 18(1):679. DOI: 10.1186/s13018-023-04168-8.PMID: 37705028

    file

    download